Insider holders · CIK 0001936258
NewAmsterdam Pharma Co N.V. · NAMS
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Michael H. DavidsonChief Executive Officer | 792,923 | 285,715 | 1,078,638 | Sep 15, 2026 · 4:30 pm EDT | Form 4 |
| Johannes Jacob Pieter KasteleinChief Scientific Officer | 53,500 | 69,302 | 122,802 | Aug 25, 2026 · 4:30 pm EDT | Form 4 |
| Louise Frederika KooijChief Accounting Officer | 24,353 | — | 24,353 | Jul 22, 2026 · 4:05 pm EDT | Form 4 |
| John W SmitherDirector | 8,760 | — | 8,760 | Sep 9, 2026 · 4:30 pm EDT | Form 4 |
| Robert William GunningVice President, Controller | 3,200 | — | 3,200 | Sep 3, 2026 · 4:30 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.